$ZDGE
Zedge, Inc. Stock $zdge

$zdge Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000121390024091735 Filed on October 29, 2024

Income Statement

Concept	2024 Q3	2024	2023 Q3
Revenue	$7.581M	$30.09M	$6.632M
YoY Change	14.31%	10.46%	-10.04%
Cost Of Revenue	$460.0K	$28.00M	$480.0K
YoY Change	-4.17%	1148.88%	-18.37%
Gross Profit	$7.121M	$2.091M	$6.152M
YoY Change	15.75%	-91.64%	-9.32%
Gross Profit Margin	93.93%	6.95%	92.76%
Selling, General & Admin	$6.852M	$25.63M	$5.144M
YoY Change	33.2%	17.24%	-0.29%
% of Gross Profit	96.22%	1225.49%	83.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$334.0K	$1.074M	$764.0K
YoY Change	-56.28%	12.7%	-2.68%
% of Gross Profit	4.69%	51.36%	12.42%
Operating Expenses	$7.186M	$25.63M	$5.908M
YoY Change	21.63%	17.24%	-0.61%
Operating Profit	-$65.00K	-$11.81M	$244.0K
YoY Change	-126.64%	70.81%	-70.95%
Interest Expense	$225.0K	$436.0K	$151.0K
YoY Change	49.01%	-80.96%	-96.14%
% of Operating Profit			61.89%
Other Income/Expense, Net
YoY Change
Pretax Income	$160.0K	-$11.37M	$395.0K
YoY Change	-59.49%	73.2%	-91.68%
Income Tax	$199.0K	-$2.198M	$240.0K
% Of Pretax Income	124.38%		60.76%
Net Earnings	-$39.00K	-$9.171M	$155.0K
YoY Change	-125.16%	50.29%	-96.58%
Net Earnings / Revenue	-0.51%	-30.48%	2.34%
Basic Earnings Per Share		-$0.65
Diluted Earnings Per Share	$0.00	-$0.65	$0.01
COMMON SHARES
Basic Shares Outstanding		14.09M shares
Diluted Shares Outstanding		14.09M shares

Balance Sheet

Concept	2024 Q3	2024	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.00M	$20.00M	$18.13M
YoY Change	10.33%	10.33%	6.09%
Cash & Equivalents	$20.00M	$20.00M	$18.13M
Short-Term Investments
Other Short-Term Assets	$593.0K	$593.0K	$569.0K
YoY Change	4.22%	4.22%	43.69%
Inventory
Prepaid Expenses	$593.0K		$569.0K
Receivables	$3.406M	$3.406M	$2.883M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$24.00M	$24.00M	$21.58M
YoY Change	11.22%	11.22%	8.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.306M	$2.520M	$2.186M
YoY Change	5.49%	-1.02%	31.69%
Goodwill	$1.824M		$1.961M
YoY Change	-6.99%		-81.82%
Intangibles	$5.369M		$18.71M
YoY Change	-71.3%		-11.02%
Long-Term Investments
YoY Change
Other Assets	$355.0K	$4.485M	$556.0K
YoY Change	-36.15%	120.07%	39.0%
Total Long-Term Assets	$14.20M	$14.20M	$25.25M
YoY Change	-43.78%	-43.78%	-27.29%
TOTAL ASSETS
Total Short-Term Assets	$24.00M	$24.00M	$21.58M
Total Long-Term Assets	$14.20M	$14.20M	$25.25M
Total Assets	$38.20M	$38.20M	$46.83M
YoY Change	-18.44%	-18.44%	-14.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.113M	$1.113M	$669.0K
YoY Change	66.37%	66.37%	-43.31%
Accrued Expenses	$301.0K	$2.551M	$2.676M
YoY Change	-88.75%	4.46%	-7.66%
Deferred Revenue	$2.168M		$2.414M
YoY Change	-10.19%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.250M	$6.250M	$5.759M
YoY Change	8.53%	8.53%	-33.48%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$1.985M
YoY Change		-100.0%
Other Long-Term Liabilities	$118.0K	$1.049M	$223.0K
YoY Change	-47.09%	370.4%	320.75%
Total Long-Term Liabilities	$118.0K	$1.049M	$2.208M
YoY Change	-94.66%	-52.49%	4066.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.250M	$6.250M	$5.759M
Total Long-Term Liabilities	$118.0K	$1.049M	$2.208M
Total Liabilities	$7.299M	$7.299M	$7.967M
YoY Change	-8.38%	-8.38%	-23.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.11M		-$3.942M
YoY Change	232.65%		-282.5%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$30.90M	$30.90M	$38.86M
YoY Change
Total Liabilities & Shareholders Equity	$38.20M	$38.20M	$46.83M
YoY Change	-18.44%	-18.44%	-14.27%

Cashflow Statement

Concept	2024 Q3	2024	2023 Q3
OPERATING ACTIVITIES
Net Income	-$39.00K	-$9.171M	$155.0K
YoY Change	-125.16%	50.29%	-96.58%
Depreciation, Depletion And Amortization	$334.0K	$1.074M	$764.0K
YoY Change	-56.28%	12.7%	-2.68%
Cash From Operating Activities	$695.0K	$5.850M	$419.0K
YoY Change	65.87%	85.01%	135.39%
INVESTING ACTIVITIES
Capital Expenditures	$166.0K	$47.00K	$293.0K
YoY Change	-43.34%	-12.96%	-304.9%
Acquisitions		$4.000M
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$166.0K	-$1.194M	-$293.0K
YoY Change	-43.34%	-50.7%	104.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$646.0K
YoY Change		-59.52%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-481.0K	-$2.643M	-141.0K
YoY Change	241.13%	-782.95%	-7150.0%
NET CHANGE
Cash From Operating Activities	695.0K	$5.850M	419.0K
Cash From Investing Activities	-166.0K	-$1.194M	-293.0K
Cash From Financing Activities	-481.0K	-$2.643M	-141.0K
Net Change In Cash	48.00K	$1.873M	-15.00K
YoY Change	-420.0%	80.1%	-140.54%
FREE CASH FLOW
Cash From Operating Activities	$695.0K	$5.850M	$419.0K
Capital Expenditures	$166.0K	$47.00K	$293.0K
Free Cash Flow	$529.0K	$5.803M	$126.0K
YoY Change	319.84%	86.71%	-60.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023	zdge	Incremental Common Shares Attributableto Dilutiveof Deferred Stock Units IncrementalCommonSharesAttributabletoDilutiveofDeferredStockUnits		shares
CY2023Q3	zdge	Derivative Liability For Foreign Exchange Contracts DerivativeLiabilityForForeignExchangeContracts		usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-07-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--07-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	1-37782
CY2024	dei	Entity Registrant Name EntityRegistrantName	Zedge, Inc.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3199071
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	1178 Broadway
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	3rd Floor #1450
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10001
CY2024	dei	City Area Code CityAreaCode	(330)
CY2024	dei	Local Phone Number LocalPhoneNumber	577-3424
CY2024	dei	Security12b Title Security12bTitle	Class B common stock, par value $0.01 per share
CY2024	dei	Trading Symbol TradingSymbol	ZDGE
CY2024	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Public Float EntityPublicFloat	38300000	usd
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	dei	Auditor Firm AuditorFirmId	1195
CY2024	dei	Auditor Name AuditorName	UHY LLP
CY2024	dei	Auditor Location AuditorLocation	New York
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19998000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18125000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3406000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2883000	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	593000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	569000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	23997000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	21577000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2306000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2186000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5369000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18709000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	1824000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1961000	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4344000	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1842000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	355000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	556000	usd
CY2024Q3	us-gaap	Assets Assets	38195000	usd
CY2023Q3	us-gaap	Assets Assets	46831000	usd
CY2024Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1113000	usd
CY2023Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	669000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2969000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2676000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2168000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2414000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6250000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5759000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1985000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	931000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	118000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	223000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	7299000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	7967000	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2400000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2400000	shares
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	48263000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	46122000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1832000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1537000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13113000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3942000	usd
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1051000	shares
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	833000	shares
CY2024Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2576000	usd
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1930000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	30896000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	38864000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38195000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46831000	usd
CY2024	us-gaap	Revenues Revenues	30091000	usd
CY2023	us-gaap	Revenues Revenues	27241000	usd
CY2024	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1859000	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2242000	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25625000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21857000	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2454000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3269000	usd
CY2024	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	11958000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8727000	usd
CY2023	zdge	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-1943000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-11805000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-6911000	usd
CY2024	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	626000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	311000	usd
CY2024	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-190000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	36000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11369000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6564000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2198000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-462000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-9171000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6102000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	295000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	146000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-295000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-146000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9466000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6248000	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14092000	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14096000	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14092000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14096000	shares
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	44188000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2519000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1596000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	146000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6102000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	38864000	usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	usd
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2141000	usd
CY2024	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	646000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	295000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-9171000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	30896000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-9171000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6102000	usd
CY2024	us-gaap	Depreciation Depreciation	56000	usd
CY2023	us-gaap	Depreciation Depreciation	60000	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1382000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2316000	usd
CY2024	zdge	Amortization Of Capitalized Software And Technology Development Costs AmortizationOfCapitalizedSoftwareAndTechnologyDevelopmentCosts	1016000	usd
CY2023	zdge	Amortization Of Capitalized Software And Technology Development Costs AmortizationOfCapitalizedSoftwareAndTechnologyDevelopmentCosts	893000	usd
CY2024	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	15000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	2141000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2519000	usd
CY2024	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	11958000	usd
CY2024	zdge	Impairment Of Investment In Privately Held Company ImpairmentOfInvestmentInPrivatelyHeldCompany	50000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2502000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-981000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8727000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1943000	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	523000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	472000	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	24000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	173000	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-45000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-14000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	722000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-711000	usd
CY2024	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	685000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-988000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5850000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3162000	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	962000	usd
CY2024	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1147000	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1406000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1194000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2422000	usd
CY2024	us-gaap	Repayments Of Debt RepaymentsOfDebt	2000000	usd
CY2024	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	646000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1596000	usd
CY2024	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2000000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	18000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2643000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	387000	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-140000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-87000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1873000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1040000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18125000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17085000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19998000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18125000	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	272000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	795000	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	66000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	118000	usd
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of our consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, as well as related disclosure of contingent assets and liabilities. Actual results could differ materially from our estimates due to risks and uncertainties, including uncertainty in the economic environment due to various global events. To the extent that there are material differences between these estimates and actual results, our financial condition or operating results will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis.</p>
CY2024	zdge	Percentage Of Purchase Licensed PercentageOfPurchaseLicensed	0.30	pure
CY2024	zdge	Percentage Of Subscriptions PercentageOfSubscriptions	0.30	pure
CY2024Q3	zdge	Gross Revenue Percentage GrossRevenuePercentage	0.70	pure
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentration of Credit Risk and Significant Customers</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash, cash equivalents and trade accounts receivable. We hold cash and cash equivalents at several major financial institutions, which may exceed FDIC insured limits. Historically, the Company has not experienced any losses due to such concentration of credit risk. The Company’s temporary cash investments policy is to limit the dollar amount of investments with any one financial institution and monitor the credit ratings of those institutions. While we may be exposed to credit losses due to the nonperformance of the holders of its deposits, we do not expect the settlement of these transactions to have a material effect on its results of operations, cash flows or financial condition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We routinely assess the financial strength of our customers. As a result, we believe that our accounts receivable credit risk exposure is limited and have not experienced significant write-downs in our accounts receivable balances. In the fiscal year ended July 31, 2024, two customers represented 31% and 9% of our revenue. In the fiscal year ended July 31, 2023, two customers represented 26% and 16% of our revenue. At July 31, 2024, three customers represented 37%, 15% and 10% of our accounts receivable balance and at July 31, 2023, two customers represented 36% and 18% of our accounts receivable balance. All of these significant customers are advertising exchanges operated by leading companies, and the receivables represent many smaller amounts due from advertisers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3	us-gaap	Other Investments OtherInvestments	0	usd
CY2024	us-gaap	Gain Loss On Investments GainLossOnInvestments	50000	usd
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	9800000	usd
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	12200000	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14092000	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14096000	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14092000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14096000	shares
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1299000	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1469000	shares
CY2024	us-gaap	Revenues Revenues	30091000	usd
CY2023	us-gaap	Revenues Revenues	27241000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2100000	usd
CY2024Q3	us-gaap	Foreign Currency Fair Value Hedge Liability At Fair Value ForeignCurrencyFairValueHedgeLiabilityAtFairValue	51000	usd
CY2023Q3	us-gaap	Foreign Currency Fair Value Hedge Asset At Fair Value ForeignCurrencyFairValueHedgeAssetAtFairValue	19000	usd
CY2022	zdge	Fair Value Additional Disclosure FairValueAdditionalDisclosure	5904000	usd
CY2022	us-gaap	Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions	-3961000	usd
CY2022Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1943000	usd
CY2023	us-gaap	Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions	-1943000	usd
CY2023Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	1900000	usd
CY2024Q3	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	1000000000	usd
CY2024Q3	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	907331000	eur
CY2024	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-245000	usd
CY2023	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	14000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11141000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9975000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8835000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7789000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2306000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2186000	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1074000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	958000	usd
CY2022Q2	zdge	Purchase Price Of Equity Securities PurchasePriceOfEquitySecurities	8400000	usd
CY2023Q3	us-gaap	Business Combination Assets Arising From Contingencies Amount Recognized Other Than At Fair Value BusinessCombinationAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue	0	usd
CY2024	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4000000	usd
CY2024	zdge	Cash Retention Bonus CashRetentionBonus	1300000	usd
CY2023	zdge	Cash Retention Bonus CashRetentionBonus	1100000	usd
CY2024	zdge	Aggregated Cash Retention Bonus Payments AggregatedCashRetentionBonusPayments	500000	usd
CY2024Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	8900000	usd
CY2024	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	180000	usd
CY2024Q3	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	2800000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15320000	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	11900000	usd
CY2024Q3	us-gaap	Escrow Deposit EscrowDeposit	2700000	usd
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets	6700000	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets	4800000	usd
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets	917000	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets	962000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	447000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	447000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	447000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	447000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3581000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5369000	usd
CY2023	zdge	Non Cash Impairment Charge NonCashImpairmentCharge	8700000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	10788000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8727000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-100000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1961000	usd
CY2024	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-137000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	1824000	usd
CY2024Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	8700000	usd
CY2024Q3	zdge	Accrued Payroll And Bonuses AccruedPayrollAndBonuses	1416000	usd
CY2023Q3	zdge	Accrued Payroll And Bonuses AccruedPayrollAndBonuses	1310000	usd
CY2024Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	690000	usd
CY2023Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	593000	usd
CY2024Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	59000	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	63000	usd
CY2024Q3	zdge	Due To Artists DueToArtists	242000	usd
CY2023Q3	zdge	Due To Artists DueToArtists	226000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	301000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	301000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	85000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	124000	usd
CY2024Q3	zdge	Derivative Liability For Foreign Exchange Contracts DerivativeLiabilityForForeignExchangeContracts	51000	usd
CY2024Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	123000	usd
CY2023Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	51000	usd
CY2024Q3	zdge	Due To Related Party Idt DueToRelatedPartyIDT	2000	usd
CY2023Q3	zdge	Due To Related Party Idt DueToRelatedPartyIDT	8000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2969000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2676000	usd
CY2024	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4000000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	214000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	360000	usd
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	140000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	139000	usd
CY2024	us-gaap	Short Term Lease Cost ShortTermLeaseCost	43000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	41000	usd
CY2024	us-gaap	Variable Lease Cost VariableLeaseCost	96000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	89000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M23D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0377	pure
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0529	pure
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	81000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	91000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	54000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	226000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	216000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11779000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-6724000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	410000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	160000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11369000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6564000	usd
CY2024	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	154000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	90000	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	124000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	413000	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	26000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	16000	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	304000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	519000	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2337000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1004000	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-165000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	23000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2502000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-981000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2198000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-462000	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2387000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1378000	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-146000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	36000	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	185000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-55000	usd
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-19000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-18000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	832000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	57000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	306000	usd
CY2024	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	112000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-185000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2198000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-462000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3561000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	882000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	1840000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	1840000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	52000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	6000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	179000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	162000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	523000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	483000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	214000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	309000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6369000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3682000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2025000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1840000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4344000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1842000	usd
CY2023Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1840000	usd
CY2024	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	185000	usd
CY2024Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2025000	usd
CY2022Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1895000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-55000	usd
CY2023Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1840000	usd
CY2024	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	4500	usd
CY2023	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	4500	usd
CY2024	zdge	Amortizes Us Activities AmortizesUSActivities	P5Y
CY2024	zdge	Amortize Non Us Activities AmortizeNonUSActivities	P15Y
CY2024	zdge	Amortize Book Purposes AmortizeBookPurposes	P3Y
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	2141000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2519000	usd
CY2024	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17000	usd
CY2024	zdge	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grant Date Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateTerm	P10Y
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	104000	usd
CY2022Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.27
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	87000	usd
CY2023	us-gaap	Other Expenses OtherExpenses	52000	usd
CY2024	zdge	Recognized Expenses RecognizedExpenses	35000	usd
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.877	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.90	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.041	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.039	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	857000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.76
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M17D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	763000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	58000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.35
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.19
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	57000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.83
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	856000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.79
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y11M23D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	346000	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	18000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.45
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.19
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.96
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	867000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.81
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y25D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1597000	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	786000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.75
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y7M13D
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1493000	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.84
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.78
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2000	usd
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	143000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	215000	usd
CY2024	us-gaap	Amortization Of Esop Award AmortizationOfESOPAward	1200000	usd
CY2023	us-gaap	Amortization Of Esop Award AmortizationOfESOPAward	1300000	usd
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	213000	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	237000	shares
CY2021Q3	zdge	Deferred Stock Units Description DeferredStockUnitsDescription	On September 7, 2021, the Company granted a total of 291,320 DSUs to 64 of its employees and consultants. Each DSU represents the right to receive one share of the Company’s Class B common stock.30% of the DSU’s (or 87,396) had service vesting conditions only, with a vesting schedule of 25% on September 7, 2022, 33% on September 7, 2023, and the remaining 42% on September 7, 2024. Vesting of the remaining 70% of the DSUs (or 203,924) is subject to continued service as well as a market condition. These DSUs will vest if the grantee remains in service to the Company and only if the aggregate market capitalization of the Company’s equity securities has reached or exceeded $451 million for five consecutive trading days between the grant date and the vest date. Subject to satisfaction of both of those conditions, these DSU’s with both service and market conditions have a vesting schedule of 25% September 7, 2022, up to 58% (the 25% eligible to vest in 2022 and an additional 33%) on September 7, 2023, and up to 100% on September 7, 2024. In the event the market capitalization condition has not been met prior to a vesting date, but is met by a subsequent vesting date, all DSUs with a market condition eligible for vesting prior to that date shall vest. In the event that the market capitalization condition has not been met by September 7, 2024, the DSUs with a market condition shall expire.
CY2024Q3	us-gaap	Share Price SharePrice	7.19
CY2024Q3	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	1500000	usd
CY2024	zdge	Service Condition Grant Date Fair Value ServiceConditionGrantDateFairValue	1300000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	202038000	shares
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	48000	usd
CY2024	us-gaap	Legal Fees LegalFees	125000000	usd
CY2023	us-gaap	Legal Fees LegalFees	125000000	usd
CY2024	us-gaap	Professional Fees ProfessionalFees	81000000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	81000000	usd
CY2024	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	2000000	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	8000000	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	28000000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	19000000	usd
CY2024	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	30091000	usd
CY2023	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	27241000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-11805000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-6911000	usd
CY2024Q3	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	8030000	usd
CY2023Q3	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	21400000	usd
CY2024Q3	us-gaap	Assets Assets	38195000	usd
CY2023Q3	us-gaap	Assets Assets	46831000	usd
CY2016Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2500000	usd
CY2024	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.05	pure
CY2024	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	10000000	usd
CY2024	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	2000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	2000000	usd
CY2022Q4	zdge	Line Of Credit Facility Remaining Available Drawdown LineOfCreditFacilityRemainingAvailableDrawdown	5000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	1000000	usd
CY2024Q3	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.10	pure
CY2023Q4	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	2000000	usd
CY2016Q4	zdge	Line Of Credit Facility Foreign Currency Exchange LineOfCreditFacilityForeignCurrencyExchange	5000000	usd
CY2016Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	7500000	usd
CY2016Q4	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.10	pure
CY2016Q4	us-gaap	Shortterm Debt Maximum Amount Outstanding During Period ShorttermDebtMaximumAmountOutstandingDuringPeriod	1900000	usd
CY2016Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	190000	usd
CY2024	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	49000000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	45000000	usd
CY2024Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1650000000	usd
CY2024Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1497079000	eur
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent		usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2024	zdge	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration		usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2023	zdge	Impairment Of Investment In Privately Held Company ImpairmentOfInvestmentInPrivatelyHeldCompany		usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2024	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2024	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2024	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2024	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2024	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends		shares
CY2023	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends		shares
CY2024	zdge	Incremental Common Shares Attributableto Dilutiveof Deferred Stock Units IncrementalCommonSharesAttributabletoDilutiveofDeferredStockUnits		shares
CY2021Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure		usd
CY2023Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure		usd
CY2022Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2024Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrent
CY2023Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrent
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies		usd
CY2024	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions		usd
CY2023	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense		usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001667313
CY2024	zdge	Balance Of Maximum Debt BalanceOfMaximumDebt	To be agreed upon

Files In Submission

Name	View Source	Status
0001213900-24-091735-index-headers.html	Edgar Link	pending
0001213900-24-091735-index.html	Edgar Link	pending
0001213900-24-091735.txt	Edgar Link	pending
0001213900-24-091735-xbrl.zip	Edgar Link	pending
ea0218596-10k_zedge.htm	Edgar Link	pending
ea021859601ex10-10_zedge.htm	Edgar Link	pending
ea021859601ex21-01_zedge.htm	Edgar Link	pending
ea021859601ex23-01_zedge.htm	Edgar Link	pending
ea021859601ex31-01_zedge.htm	Edgar Link	pending
ea021859601ex31-02_zedge.htm	Edgar Link	pending
ea021859601ex32-01_zedge.htm	Edgar Link	pending
ea021859601ex32-02_zedge.htm	Edgar Link	pending
ea021859601ex97-01_zedge.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
ea0218596-10k_zedge_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zdge-20240731.xsd	Edgar Link	pending
zdge-20240731_cal.xml	Edgar Link	unprocessable
zdge-20240731_def.xml	Edgar Link	unprocessable
zdge-20240731_lab.xml	Edgar Link	unprocessable
zdge-20240731_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZDGE
Zedge, Inc. Stock $zdge

2024 Q3 Form 10-K Financial Statement

#000121390024091735 Filed on October 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZDGE Zedge, Inc. Stock $zdge

2024 Q3 Form 10-K Financial Statement

#000121390024091735 Filed on October 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZDGE
Zedge, Inc. Stock $zdge